Turn Therapeutics (TTRX) Non-Current Assets (2024 - 2026)

Turn Therapeutics has reported Non-Current Assets for 3 years, with the latest figure at $7.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets changed N/A year-over-year to $7.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.1 million (changed N/A YoY), and the FY2025 full-year result was $7.0 million, up 632.5% from the prior year.
• Non-Current Assets for Q1 2026 stood at $7.2 million, up from $7.0 million in the prior quarter.
• The five-year high for Non-Current Assets was $7.2 million in Q1 2026, with the low at $950965.0 in Q4 2024.
• Average Non-Current Assets over 3 years is $4.0 million, with a median of $4.0 million recorded in 2025.
• Peak annual rise in Non-Current Assets reached 632.5% in 2025, while the deepest fall reached 632.5% in 2025.
• Tracing TTRX's Non-Current Assets over 3 years: stood at $950965.0 in 2024, then surged by 632.5% to $7.0 million in 2025, then gained by 3.24% to $7.2 million in 2026.
• The last three Non-Current Assets figures came in at $7.2 million (Q1 2026), $7.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison